5,6-diaryl-pyrazine-2-amide derivatives as CB1 antagonists

Details for Australian Patent Application No. 2002352425 (hide)

Owner ASTRAZENECA AB

Inventors Berggren, Anna, Ingrid Kristina; Terricabras, Emma; Elebring, Stig, Thomas; Greasley, Peter; Bostrom, Stig Jonas; Wilstermann, Johan Michael

Agent Davies Collison Cave

Pub. Number AU-A-2002352425

PCT Number PCT/GB02/05742

PCT Pub. Number WO2003/051851

Priority 0104330-6 19.12.01 SE

Filing date 18 December 2002

Wipo publication date 30 June 2003

International Classifications

C07D 241/24 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 031/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 025/18 Drugs for disorders of the nervous system

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 0104330-6 19.12.01 SE

28 August 2003 Application Open to Public Inspection

  Published as AU-A-2002352425

3 August 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002352426-3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of PPAR-alpha

2002352424-SOLUTION-PHASE PROCESS FOR THE MANUFACTURE OF DECAPEPTIDE